Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Inspire Medical Systems, Inc. Common Stock
(NY:
INSP
)
42.43
-1.41 (-3.22%)
Streaming Delayed Price
Updated: 12:53 PM EDT, May 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Inspire Medical Systems, Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
5 Insightful Analyst Questions From Inspire Medical Systems’s Q1 Earnings Call
May 11, 2026
Inspire Medical Systems’ first quarter results were met with a significant negative response from the market, as management pointed to persistent challenges ...
Via
StockStory
Topics
Earnings
2 Cash-Heavy Stocks with Solid Fundamentals and 1 We Ignore
May 07, 2026
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion o...
Via
StockStory
Inspire Medical Systems (INSP) Stock Trades Down, Here Is Why
May 05, 2026
What Happened? Shares of medical technology company Inspire Medical Systems (NYSE:INSP) fell 16% in the morning session after the company lowered its full-ye...
Via
StockStory
Topics
Earnings
INSP Q1 Deep Dive: Coding Headwinds and WISER Program Drive Down Full-Year Outlook
May 05, 2026
Medical technology company Inspire Medical Systems (NYSE:INSP) announced better-than-expected revenue in Q1 CY2026, with sales up 1.6% year on year to $204.6...
Via
StockStory
Inspire Medical Systems (NYSE:INSP) Q1 Earnings Beat on Profit But Revenue Miss Sends Stock Plummeting
↗
May 04, 2026
Via
Chartmill
Topics
Earnings
Inspire Medical Systems (NYSE:INSP) Stock Plunges on Weak 2026 Outlook Despite Q4 Earnings Beat
↗
February 11, 2026
Via
Chartmill
Inspire (INSP) Q1 2026 Earnings Call Transcript
↗
May 04, 2026
Inspire (INSP) Q1 2026 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Top movers in Monday's after hours session
↗
May 04, 2026
Via
Chartmill
Inspire Medical Systems’s (NYSE:INSP) Q1 CY2026 Sales Top Estimates But Stock Drops 18.8%
May 04, 2026
Medical technology company Inspire Medical Systems (NYSE:INSP) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 1.6% year on year to $204....
Via
StockStory
Inspire (INSP) Q2 2025 Earnings Call Transcript
↗
May 04, 2026
Inspire (INSP) Q2 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Intellectual Property
Inspire Medical Systems (INSP) To Report Earnings Tomorrow: Here Is What To Expect
May 02, 2026
Medical technology company Inspire Medical Systems (NYSE:INSP) will be announcing earnings results this Monday afternoon. Here’s what to expect. Inspire Medi...
Via
StockStory
Topics
Artificial Intelligence
2 Cash-Producing Stocks for Long-Term Investors and 1 That Underwhelm
May 01, 2026
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via
StockStory
Topics
Artificial Intelligence
1 of Wall Street’s Favorite Stock Worth Investigating and 2 We Brush Off
April 13, 2026
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...
Via
StockStory
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off
April 08, 2026
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have realized stron...
Via
StockStory
1 Cash-Heavy Stock to Research Further and 2 That Underwhelm
March 13, 2026
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they strugg...
Via
StockStory
Inspire Medical Systems (INSP): Buy, Sell, or Hold Post Q4 Earnings?
March 09, 2026
Shareholders of Inspire Medical Systems would probably like to forget the past six months even happened. The stock dropped 22.7% and now trades at $62.98. Th...
Via
StockStory
Topics
Supply Chain
Winners And Losers Of Q4: Inspire Medical Systems (NYSE:INSP) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
March 05, 2026
Via
StockStory
Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP
March 02, 2026
From
Kahn Swick & Foti, LLC
Via
Business Wire
Inspire Medical Systems (INSP) Stock Trades Down, Here Is Why
February 27, 2026
Shares of medical technology company Inspire Medical Systems (NYSE:INSP) fell 7.5% in the afternoon session after the release of a key inflation report revealed prices paid to U.S. producers rose more...
Via
StockStory
Topics
Economy
Inspire Medical Systems (INSP) Stock Trades Up, Here Is Why
February 26, 2026
Shares of medical technology company Inspire Medical Systems (NYSE:INSP) jumped 19.7% in the afternoon session after reports revealed that the Centers for Medicare & Medicaid Services (CMS) is...
Via
StockStory
Topics
Economy
2 Profitable Stocks Worth Investigating and 1 We Brush Off
February 19, 2026
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Via
StockStory
Topics
Artificial Intelligence
5 Insightful Analyst Questions From Inspire Medical Systems’s Q4 Earnings Call
February 18, 2026
Inspire Medical Systems’ fourth quarter was marked by robust revenue growth and improved operating margins, yet the market responded negatively due to heightened uncertainty around reimbursement for...
Via
StockStory
Topics
Earnings
Inspire Medical Systems, Astrana Health, Evolent Health, Corcept, and Centene Stocks Trade Up, What You Need To Know
February 13, 2026
A number of stocks jumped in the afternoon session after a softer-than-expected inflation report fueled hopes for interest rate cuts by the Federal Reserve. The January Consumer Price Index (CPI), a...
Via
StockStory
Topics
Economy
Inspire Medical Systems (INSP) Stock Trades Down, Here Is Why
February 12, 2026
Shares of medical technology company Inspire Medical Systems (NYSE:INSP) fell 8.7% in the morning session after the company's weak full-year revenue guidance overshadowed its strong fourth-quarter...
Via
StockStory
Topics
Artificial Intelligence
INSP Q4 Deep Dive: Reimbursement Uncertainty Shapes Outlook Despite Strong Product Adoption
February 12, 2026
Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 12.2% year on year to $269.1 million. On the other...
Via
StockStory
Inspire Medical (INSP) Q4 2025 Earnings Transcript
↗
February 11, 2026
Inspire Medical (INSP) Q4 2025 Earnings Transcript
Via
The Motley Fool
Which stocks are moving after the closing bell on Wednesday?
↗
February 11, 2026
Via
Chartmill
Inspire Medical Systems (NYSE:INSP) Posts Better-Than-Expected Sales In Q4 CY2025 But Stock Drops
February 11, 2026
Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 12.2% year on year to $269.1 million. On the other...
Via
StockStory
Inspire Medical Systems (INSP) Q4 Earnings: What To Expect
February 09, 2026
Medical technology company Inspire Medical Systems (NYSE:INSP) will be reporting results this Wednesday after market close. Here’s what to expect.
Via
StockStory
Topics
Economy
World Trade
2 Small-Cap Stocks to Target This Week and 1 We Turn Down
February 05, 2026
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...
Via
StockStory
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.